The credit crunch: A capital bypass for life sciences?
Over at VentureBeat proper, Matt highlights a theory advanced by venture capitalist Keith Benjamin, who argues that the credit crunch now threatening the private-equity boom may have the unexpected effect of boosting returns in technology investments. (Keith puts this all down in his own words on his personal blog and in this contributed piece at VentureBeat.)
Turns out a few people have also been wondering whether a deflating private-equity bubble might also redirect capital to the… Continue Reading
The credit crunch could help venture capitalists
The current credit crunch caused by the subprime loaning crisis may help venture capital returns, and therefore start-ups.
That’s the argument of venture capitalist Keith Benjamin, of San Francisco’s Levensohn Venture Partners, as posted on his blog a few days ago, and which has been picked up by several publications, including this morning’s New York Times (the Times runs a cute graphic of a detour road sign in its story.)
Coincidentally, we asked Benjamin to write… Continue Reading